AstraZeneca Buys 20% Stake in Cambridge Antibody
88847
AstraZeneca Plc, the UK&#39;s second biggest drugmaker, bought a 19.9 percent stake in Cambridge Antibody Technology Group Plc, an unprofitable biotechnology company, for 75 million pounds ($139 million).
242889
Blackstone Group  has agreed to buy 20 percent of chemical maker China National BlueStar (Group) Corp for up to $600 million, the private equity groups said on Monday, marking its first major investment in the fast-growing market.
541099
German pharmaceuticals company Merck KGaA has taken a majority stake in Switzerland's Serono SA and was aiming at a full takeover worth 16.6 billion Swiss francs (10.46 billion euros).
282450
Mylan Laboratories Inc., the biggest US maker of generic drugs, received a $20-a-share bid from Carl Icahn, the company&#39;s largest investor and a critic of Mylan&#39;s plan to buy King Pharmaceuticals Inc.
679213
NEW YORK, December 21  - The worldâs largest video game maker Electronic Arts (ERTS.NAS) announced yesterday that it had purchased a 20% stake in its French competitor Ubisoft Entertainment.
170214
BERLIN - Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private US investment groups Cerberus Capital Management and Ampersand Ventures.
389209
AstraZeneca intends to invest over Â£120m in Cambridge Antibody Technology (CAT) through an innovative five-year research collaboration and a Â£75m equity
93143
Defense technology developer Foster-Miller Inc. of Waltham says it will be acquired for $163 million by Britain's QinetiQ Group PLC, a public-private partnership with the United Kingdom Ministry of Defense.
660344
Israel's Teva Pharmaceutical  Industries Ltd. has agreed to buy Pfizer Inc.'s Italian generic  drug marketing company and is hungry for more acquisitions, the  drugmaker said on Tuesday.
751178
ZURICH/FRANKFURT  - German drugmaker Merck KGaA   MRCG.DE on Thursday unveiled a surprise 16.6-billion-Swiss   franc ($13.26-billion) deal to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
405442
Cambridge Antibody Technology Group Plc won a court ruling awarding it higher royalties from US partner Abbott Laboratories for its help developing one of the biggest drugs from the UK&#39;s biotechnology industry.
681404
U.S. antitrust authorities on  Wednesday approved AstraZeneca Plc&#39;s  plan to buy  biotechnology company MedImmune Inc.  for more than $15  billion.
197311
In a deal valued at $20 million, Check Point Software Technologies gels a new growth strategy: buy others.
213264
Symantec has agreed to acquire @Stake, a Cambridge, Mass.-based provider of IT security consulting services. After closure of the deal, expected in October, Symantec plans to integrate @Stake&#39;s services and
260392
LONDON (CBS.MW) -- UK biotech Cambridge Antibody Technology (CATG) (UK:CAT) shares were suspended in London Monday amid a court decision.
477715
Pharmaceutical group GlaxoSmithKline (GSK) has agreed to buy antibody therapy developer Domantis for 230 million pounds.
439010
SINGAPORE : SembCorp Logistics will sell its entire 20 percent stake in Swiss logistics group Kuehne &amp; Nagel International, or KNI, for S$1.